The physicians and staff at Regional Cancer Care (RCC) actively participate in clinical cancer research. It is through clinical research that improvements or advances are made in the prevention, detection, and treatment of cancer, as well as improvements in controlling the symptoms of cancer and cancer treatment.

All of our cancer patients have the opportunity to participate in clinical research. Patients from Northwestern Ontario have participated in some of the largest studies ever conducted, which have shaped how we manage certain types of cancer.

Clinical research conducted at RCC incorporates studies offered through cooperative groups, pharmaceutical companies and some in-house research. The cooperative groups offer studies that are among the foremost in research for cancer treatment, prevention and diagnosis. Groups such as the National Cancer Institute of Canada (NCIC) or Radiation Therapy Oncology Group (RTOG) often partner with cancer research leaders such as the Mayo Clinic or MD Anderson, so patients participating in these studies at RCC have access to some of the most innovative and cutting edge treatments, tests or prevention tools available.

Click here for more information on current open trials.